University of Ioannina
Οξειδοαναγωγικές μεταβολές κατά την περιτοναϊκή κάθαρση και μέθοδοι αντιμετώπισής τους
Abstract
dc:descriptionOxidative stress defines a potential harmful condition, due to an imbalance between the formation of oxidative compounds and the protection of antioxidant defence mechanisms. There is strong evidence indicating that uraemia and end-stage renal disease are associated with excessive oxidative stress, which progresses along with the deterioration of kidney function, and exacerbates during dialysis procedures. In spite of many therapeutic advances, patients with end-stage renal disease (ESRD) receiving renal replacement therapy are at increased risk of developing cardiovascular disease, only partially explained by the “traditional” risk factors. Specifically, oxidative damage has been suggested to play a key role in accelerated atherosclerosis and endothelial dysfunction of dialyzed patients. On the other hand, this condition of increased oxidative stress is considered to play a major role in the development of ESRD complications and has been implicated as one possible mechanism of structural and functional damage of the peritoneal membrane in long-term PD patients. Peritoneal dialysis fluids also contain glucose degradation products (GDPs), which are generated during heat sterilization or prolonged storage, particularly at high temperature. GDPs accelerate the production of AGEs in the peritoneal cavity and consequently exert adverse effects on the peritoneal membrane. Generation of AGEs is accelerated in such a pro-oxidant state but also induce a further oxidative stress response, including lipid peroxidation. In PD patients, oxidative damage is aggravated by chronic inflammation, diabetes, advanced age, and losses of small molecules, into the peritoneal cavity, such as the antioxidant ascorbate. Consequently, these patients need ascorbic acid supplementation, not only because of increased loss through dialysate, but also due to reduced intake owing to nausea and loss of appetite, and increased oxidative stress. To maintain ascorbic acid in the normal range for healthy adults, daily oral intake needs to be increased above the U.S. recommended dietary allowance to 80-140 mg. The aim of this study was to compare oxidative and carbonyl stress markers between patients under continuous ambulatory peritoneal dialysis (CAPD), and healthy individuals and, furthermore to investigate the influence of vitamin C (250 mg/day orally) supplementation, alone or in combination with vitamin E (200 mg/day), on the same oxidant/ antioxidant defense parameters in CAPD patients. Twenty CAPD patients (age, 51-70 years) and 10 age-matched healthy subjects were enrolled. Oxidative/ carbonyl stress markers, such as erythrocyte antioxidant enzyme activity [superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px)], total antioxidant capacity (TAC) and malondialdehyde (MDA), both of them in serum, erythrocytes, peritoneal effluent and urine, serum thiobarbituric-acid-reactive substances (TBARS) and carbonyl compounds, were evaluated in three different 8 week periods: Before the administration of antioxidants, after the oral administration of vitamin C and after the combination of vitamins C and E. CAPD patients showed lower TAC, higher lipid peroxidation (as indicated by MDA and TBARS levels) and higher carbonyl compound levels than control subjects. The administration of vitamin C increased both erythrocyte enzyme activity. Vitamin C alone and especially in combination with vitamin E led to the significant decrease of malondialdehyde and the increase of TAC in serum, erythrocyte, urine and peritoneal effluent and the decrease of serum TBARS and carbonyl compounds level (for some parameters statistically significant). These findings indicate exacerbated oxidative stress in patients with chronic renal failure under CAPD, as evidenced by decreased TAC, increased lipid peroxidation, enhanced carbonyl compound and low antioxidant levels. Eight-week treatment with oral vitamin C plus pyridoxine alone or in combination with vitamin E (for the same period) in CAPD patients, led to the significant decrease of oxidative stress. Our study confirmed the beneficial effect of both antioxidant vitamins and especially their combination, although the vitamin E serum levels are in normal range for the majority of CAPD patients, indicating possibly a type of intracellular vitamin defect. Orally administered vitamin E is a very important antioxidant agent for CAPD patients. Low-dose vitamin C supplements should be recommended for PD patients to maintain normal antioxidant status, given that higher doses could serve as precursors of pentosidine, or might increase serum oxalic acid levels.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Μπουντούρης, Γεώργιος
- Boudouris, Georgios
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26052